Senior Financial Analyst
Emily Goldman joined Flagship Pioneering in 2021 as a senior financial analyst. In her role, she provides strategic, financial, and business insights to support senior leadership, Pioneering Medicines, and the Flagship enterprise. Her responsibilities include: financial analytics, supporting Flagship’s fundraising and investor relations activities, public portfolio and market monitoring, and assessment of key valuation creation opportunities.
Emily comes to Flagship from a career in healthcare consulting, with previous tenure at Putnam Associates in Boston, Mass., focusing on oncology and cell therapy. In addition to her professional pursuits, Emily has served as a volunteer judge for the MIT Solve Program’s annual healthcare challenge and is an active community volunteer for Boston Cares.
Emily holds a B.A. with honors from Duke University in Public Policy in the Philosophy, Politics, and Economics program, specializing in health policy.